In this work, two accurate and sensitive real-time polymerase chain reaction (PCR) assays to differentiate pathogenic Cryptococcus gattii sensu lato (s.l.) and C. neoformans sensu lato (s.l.) targeting the intergenic spacer 1 (IGS1) region from rDNA locus were developed. Specific primers were designed based on their IGS1 sequence analyses and the optimal real-time PCR assays showed that the dissociation curves generated two different melting peaks, at 82.8 and 84.2 o C for C. gattii s.l. and C. neoformans s.l., respectively. No amplifications were observed in the negative template control. The minimum limit of detection of both primers was 100 plasmid copies per reaction, and they were highly specific when tested with a range of fungal DNAs. Overall, the results showed that the designed primers completely differentiated C. gattii s.l. and C. neoformans s.l. from clinical and environmental sources with great accuracy when compared to phenotypic identification, with no cross-reactivity to other fungal DNA.
Introduction
Cryptococcus complex comprises basidiomycetous yeasts that inhabit soil contaminated with pigeon droppings, decayed wood and tree detritus. 1, 2 This encapsulated yeast causes cryptococcosis, which affects more than one million patients with AIDS. Annually, this fungal infection results in about 625,000 deaths, mainly by cryptococcal meningitis. 3, 4 Even though several species have been described, most of the reported cases are caused by two main complexes: Cryptococcus gattii sensu lato (s.l.) and C. neoformans sensu lato (s.l.). 5, 6, 7, 8 Regardless of Cryptococcus genotyping and phenotypical features, C. gattii s.l. has been classified in C. gattii (genotype AFLP4/VGI), C. bacillisporus (genotype AFLP5/VGIII), C. deuterogattii (genotype AFLP6/VGII), C. tetragattii (genotype AFLP7/VGIV) and C. decagattii (genotype AFLP10/VGIV); C. neoformans has been classified as C. neoformans (genotype AFLP1/VNI, AFLP1A/VNB/VNII and AFLP1B/VNII) and C. deneoformans (genotype AFLP2/VNIV). 7, 8 Remarkably, both species complexes display differences in their ecological niches, 1 epidemiological data, and clinical and therapeutic outcomes. 5, 6, 7, 9 C. neoformans s.l. is the most common agent of cryptococcosis, especially in immunocompromised individuals, while C. gattii s.l. has been known as an emerging pathogen that is able to infect immunocompetent individuals. 5, 6, 10, 11 Molecular epidemiology has shown great advances and brought important information about worldwide distribution of Cryptococcus species. 12 However, there is lack on epidemiological data from several countries of Africa, Asia, and Eastern Europe. 12 Complications may still remain on
Cryptococcus yeast differentiation techniques. Identification is based on culture and biochemical and molecular methods, where the yeast is differentiated by growth on Lcanavaline glycine bromothymol blue (CGB) agar followed by DNA sequencing. 13, 14 The isolation of Cryptococcus yeasts from cerebrospinal fluid, sputum or bronchoalveolar lavage fluid demand efforts but distinguishing them remains a great challenge. 15 Therefore, polymerase chain reaction (PCR) methods have been explored as a tool to identify Cryptococcus species, using as a target the ribosomal RNA (rDNA) gene cluster. 16 The rDNA locus consists of four ribosomal genes: 18S, 5.8S, 25-28S and 5S, the internal transcribed spacers (ITS) 1 and 2 and the intergenic spacers (IGS) 1 and 2.
17 ITS has been used to molecularly identify the microorganism, 18 but unfortunately, these sequences are highly conserved be- 
Material and methods

Microorganisms and culture conditions
The were also maintained at −80 o C.
DNA extraction
Genomic DNA was extracted as described by Jain et al. 23 Briefly, yeasts were grown in 10 ml of Sabouraud dextrose broth for 48 hours at 37 o C and harvested by centrifugation at 6000 × g. Cells were resuspended in lysis buffer (10 mM To use the plasmids containing the IGS1 genes from C. neoformans ATCC66031 and C. gattii ATCC56990 as homologous DNA standards of known copy numbers, both amplicons were cloned using TOPO TA cloning kit (Invitrogen, USA), according to the manufacturer's procedure. The plasmid DNAs were purified using the PureLink TM Quick plasmid miniprep kit (Invitrogen, USA), following the manufacturer's procedure, and quantified as described above. The nucleotide sequences of pCR2.1/IGS1 from PCR products of both yeasts confirmed identity of amplified fragments as IGS1. The copy numbers of each standard curve were calculated using the size of the plasmid used and Avogadro's number. 24 Cryptococcus IGS1 amplification by real-time PCR Real-time PCR runs were performed in Rotor-Gene Q 2Plex equipment (Qiagen, Germany). To optimize the primer concentrations, the reaction mixture contained 2. 
oxysporum).
All assays were carried out in duplicate on three independent experiments using the same real-time PCR cycling condition.
Genotype determination
All Cryptococcus samples and isolates were characterized by restriction fragment length polymorphism (RFLP) as described by Meyer et al., 8 using the primers URA5 (5 -atgtcccaagccctcgactccg-3 ) and SJ01 (5 -ttaagacctctgaacaccgtactc-3 ). RFLP patterns were assigned by visualization and comparing them to patterns from standard strains. generated amplicons of 260 and 280 bp, respectively, with high annealing temperature, 70 o C for both reactions (data not shown). After standardization of the reactions in conventional PCR, real-time PCR assays were optimized using genomic DNA from Cryptococcus reference strains. The results showed that the best reaction conditions were obtained with 10 μM primers (data not shown), and in addition, the dissociation curves generated showed two different melting peaks, at 82. 8 (Fig. 1B-E) . Specificity of primers was tested with a range of fungal DNA of reference strains, clinical or environmental isolates. Results showed that the primers completely differentiated all clinical and environmental isolates of C. gattii s.l. and C. neoformans s.l., and most importantly, with great accuracy when compared to phenotypic identification. In addition, no cross-reactivity was observed with samples of other fungal DNA (Table 1 ). The genotype profile by URA5 gene RFLP analysis showed a prevalence of C. neoformans VNI profile (C. neoformans) (7/8) among clinical samples, and one sample as VNII (C. neoformans); interestingly, when environmental isolates were analyzed, we found two genotype profiles, VNI (C. neoformans) (5/14) and VNIII (C. neoformans × C. deneoformans hybrid) (9/14). When C. gattii genotype profile was analyzed, we observed a prevalence of VGI profiles (C. gattii) (6/8) among clinical and environmental isolates, and two samples as VGII (C. deuterogattii). Fiocruz 
Results
Initially
− − − − P. brasiliensis EJV c − − − − Sporotrix sp. E J V c − − − − H. capsulatum IMT/HC128 EJV c − − − − T. rubrum EJV c − − − − T. asahii EJV c − − − − A. flavus EJV c − − − − A. terreus EJV c − − − − A. niger EJV c − − − − A. fumigatus EJV c − − − − F. oxysporum
Discussion
Molecular methods have been improved to obtain a better diagnosis of Cryptococcus infections. 16 Here, real-time PCR assays using specific primers that anneal IGS1 region from rDNA locus showed great differentiation resolution of C. neoformans s.l. and C. gattii s.l. samples and isolates, either clinical or environmental sources. Detection limit of 100 plasmid copies per reaction suggest a sensitivity of two cells per reaction, estimating that the rDNA gene, in C. neoformans complex, is represented by approximately 55 copies per haploid genome. 25 The values presented here showed detection limits higher than in other studies (10 copies); 26, 27 however, these authors used a probe-based approach that is known to be more sensitive than when an intercalating dye-approach (e.g., SybrGreen) is used. Therefore, the implementation of these assays by clinical laboratories will be more affordable. Particularly, real-time PCR assay provides a simple method for determining the amount of target sequence or gene that is present in a sample, reducing the time of assay and eliminating the necessity of post-amplification processing and detection. 17 Moreover, no cross-reactivity was observed when other fungal DNAs were tested, a key aspect for fungal diagnosis, due to potential environmental contamination. A limit of this study is the absence of genotype VGIV isolates (C. tetragattii/C.decagattii), and this fact is explained by the occurrence of these two species worldwide. 7 27 and D2 region in a DNA sequencing assay. 13 C. gattii s.l. and C. neoformans s.l. differentiation using these regions was useless due to the high nucleotide sequence similarity between them, making it difficult to distinguish even when DNA sequencing was performed. Best results were obtained using the sequencing of the IGS region 14 and high-resolution melting analysis. 34 Other techniques or genes are also available, such as matrixassisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), 35 Hyperbranched rolling cycle amplification (HRCA) 36 and singleplex PCR; 37 however, most of them are costly or time-consuming methods. Overall, this study showed that although several Cryptococcus species were tested, the designed specific primers were able to differentiate C. gattii s.l. and C. neoformans s.l. Finally, improvement of pathogenic Cryptococcus species identification will allow quicker and specific implementation of antifungal therapeutics reducing morbidity and mortality.
